Editorial Board
Editor-in-Chief
- J. R. Guyton, Duke University Medical Center, Durham, North Carolina, United States of America
Associate Editors
- W. E. Boden, VA New England Healthcare System, Bedford, Massachusetts, United States of America, Section Specialty - Epidemiology, Clinical trials, and Preventive Cardiology
- E.A. Brinton, Utah Foundation for Biomedical Research, Atherometabolic Research, Salt Lake City, Utah, United States of America, Section Specialty: Lipidology
- W.V. Brown, Emory University, Atlanta, Georgia, United States of America, Section Specialty: Lipoprotein Metabolism and Clinical Lipidology
- A. Cuevas, Centro Avanzado de Medicina Metabólica y Nutrición, Santiago, Chile, Section Specialty: Obesity, Nutrition, Atherosclerosis, and Dislipidemias
- M. Davidson, University of Chicago Pritzker School of Medicine, Chicago, Illinois, United States of America, Section Specialty: Clinical Trials
- D. DeSilvey, Northern Light Blue Hill Memorial Hospital, Blue Hill, Maine, United States of America, Section Specialty: Cardiovascular Medicine
- D. L. Dixon, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, United States of America, Section Specialty: Pharmacotherapy, Cardiometabolic Disease, and Health Outcomes Research
- P.B. Duell, Oregon Health & Science University, Portland, Oregon, United States of America, Section Specialty: Endocrinology and diabetes, Preventive Cardiology
- J. Falko, University of Colorado Anschutz Medical Campus Division of Endocrinology Metabolism and Diabetes, Aurora, Colorado, United States of America, Section Specialty: Endocrinology, Metabolism & Diabetes
- D. Gaudet, University of Montreal, Montréal, Québec, Canada, Section Specialty: Hypertriglyceridemia, Genetic Lipid Disorders, Cardiometabolic Risk
- E. Gill, University of Washington, Seattle, Washington, United States of America, Section Specialty: Cardiology
- I.J. Goldberg, NYU Langone Health, New York, New York, United States of America, Section Specialty: Basic Lipid Physiology, Lipolytic Enzymes
- R.A. Hegele, Western University, London, Ontario, Canada, Genetics, Lipids, Hypercholesterolemia, Hypertriglyceridemia, Atherosclerosis
- L. Hemphill, MASSACHUSETTS GENERAL HOSP, Boston, Massachusetts, United States of America, Section Specialty: Clinical Trials, Familial hypercholesterolemia, LDL apheresis
- M. Ito, Oregon Health & Science University, Portland, Oregon, United States of America, Section Specialty: Pharmacology, Clinical Lipidology, Familial hypercholesterolemia
- T. Jacobson, Emory University, Atlanta, Georgia, United States of America, Section Specialty: Epidemiology, Disease Prevention, Clinical Trials
- W.G. Jerome, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America, Section Specialty: Pathology, Microbiology, and Immunology
- P. Jones, Baylor College of Medicine, Houston, Texas, United States of America, Section Specialty: Lipidology, Atheroclerosis
- D. Kalra, University of Louisville, Louisville, Kentucky, United States of America, Section Specialty: Risk Assessment, High-risk Populations, Guidelines, Atherosclerosis Imaging
- W. Karmally, Columbia University Irving Medical Center, New York, New York, United States of America, Section Specialty: Women and Heart disease, Prevention Cardiology, Nutrition
- R.M. Krauss, Children's Hospital Oakland Research Institute, Oakland, California, United States of America, Section Specialty: Endocrinology and Metabolism
- P. Kris-Etherton, The Pennsylvania State University, University Park, Pennsylvania, United States of America, Section Specialty, Nutrition Science/Dietetics
- R. La Forge, Duke University Hospital, Durham, North Carolina, United States of America, Section Specialty: Cardiac Rehabilitation, Metabolism, Nutrition, Lifestyle
- B. Lamarche, Laval University, Québec, Quebec, Canada, Section Specialty: Nutrition, Dietary intervention, Epidemiology
- E. Lerma, University of Illinois Chicago College of Medicine, Chicago, Illinois, United States of America
- M. Lopes-Virella, Medical University of South Carolina, Department of Medicine, Charleston, South Carolina, United States of America, Section Specialty: Diabetes & Immunology
- R.H. Mackey, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America, Section Specialty: Epidemiology
- M.J. Malloy, University of California San Francisco, San Francisco, California, United States of America, Section Specialty: Pediatric Lipidology, Genetics, Lipoproteins
- S. S. Martin, Johns Hopkins Hospital and Health System, Baltimore, Maryland, United States of America, Digital health, Mobile health, Health technology, Innovation, Preventive cardiology, Cardiovascular risk, Lipids, Big data, Precision medicine, Patient-centered care
- J. Plutzky, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Section Specialty: Cardiovascular Disease, Lipid Disorders, Vascular Medicine
- G. Pokrywka, Baltimore Lipid Center, Towson, Maryland, United States of America, Section Specialty: Clinical Lipidology, Advanced Lipid Protein Testing, Women's Health and Menopause
- A.T. Remaley, National Institutes of Health, Bethesda, Maryland, United States of America, ABC transporter, cardiovascular disease, lipoprotein metabolism
- A. Rohatgi, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
- R. Santos, University of Sao Paulo Heart Institute, SAO PAULO, Brazil, Familial Hypercholesterolemia, Imaging in Atherosclerosis, Preventive Cardiology
- D. Soffer, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America
- P. Toth, University of Illinois Chicago College of Medicine at Peoria, Peoria, Illinois, United States of America, Section Specialty: Lipidology, Preventive Cardiology
- G. L. Vega, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America, Lipidology, Obesity
- K. Vijayaraghavan, The University of Arizona College of Medicine Phoenix, Phoenix, Arizona, United States of America, Section Specialty: Lipidology, Heart Failure, Diabetes and Cardiorenal Connectome
- S.S. Virani, Baylor College of Medicine, Houston, Texas, United States of America, Section Specialty: Cardiovascular Outcomes and Guidelines
- G. Watts, The University of Western Australia, Perth, Western Australia, Australia, Lipids, Familial hypercholesterolaemia, Lp(a), Inherited heart disease, Obesity, Metabolism
- A.S. Wierzbicki, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom, Section Specialty: Cardiology, Internal Medicine, Diabetology
- R. A. Wild, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America
- D. Wilson, Phoenix Children's Hospital, Phoenix, Arizona, United States of America, Section Speciality: Pediatric Lipid Management
Editorial Board
- N. Abate, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
- M. Al-Mallah, Henry Ford Heart and Vascular Institute Cardiology Heart Care, Detroit, Michigan, United States of America
- E. Alhaj, WESTSIDE MEDICAL CENTER, Louisville, Kentucky, United States of America
- H. Bays, Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky, United States of America
- R. C. Block, University of Rochester Medical Center, Department of Public Health Sciences, Rochester, New York, United States of America
- M. B. Boffa, Western University, London, Ontario, Canada
- M. Bottorff, University of Charleston School of Pharmacy, Charleston, West Virginia, United States of America
- L. Braun, Rush University Medical Center, Chicago, Illinois, United States of America
- H. Contois, Sun Diagnostics, New Gloucester, Maine, United States of America
- W. Cromwell, Presbyterian Cardiovascular Institute, Dept. of Atherosclerosis and Lipoprotein Disorders, Charlotte, North Carolina, United States of America
- J. Freeman, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania, United States of America
- S.A. Geraci, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America
- R.B. Goldberg, University of Miami School of Medicine, Miami, Florida, United States of America
- A. Gotto Jr., Weill Cornell Medicine, New York, New York, United States of America
- D. Karalis, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
- K. Maki, MB Clinical Research and Consulting LLC, Addison, Illinois, United States of America
- C. McNeal, Baylor Scott & White Neuroscience Institute, Temple, Texas, United States of America
- D. Meyers, The University of Kansas Medical Center, Kansas City, Kansas, United States of America
- M. Miller, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
- P. Moriarty, The University of Kansas Medical Center, Kansas City, Kansas, United States of America
- P. Morris, Medical University of South Carolina, Charleston, South Carolina, United States
- A. Nafziger, Bassett Healthcare, Cooperstown, New York, United States of America
- S. Nash, Esperion Therapeutics Inc, Ann Arbor, Michigan, United States of America
- S. B. Patel, University of Cincinnati, Cincinnati, Ohio, United States of America
- D. Rader, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
- V. Raghavan, The Ohio State University, Columbus, Ohio, United States of America
- M. Richman, The Center for Cholesterol Management, Los Angeles, California, United States of America
- G. Ruotolo, Eli Lilly and Company, Indianapolis, Indiana, United States of America
- F. Sacks, Harvard University T H Chan School of Public Health, Boston, Massachusetts, United States of America
- M. Shapiro, Oregon Health & Science University, Portland, Oregon, United States of America
- S. Shurmur, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
- D.A. Smith, Mount Sinai Medical Center, New York, New York, United States of America
- M. Sweeney, Emory University School of Medicine, Atlanta, Georgia, United States of America
- J. Underberg, CareMount Medical Internal Medicine Department, New York, New York, United States of America
- R. Vicari, Mima Century Research Associates, Melbourne, Florida, United States of America
- G. Warnick, Berkeley HeartLab Inc, South San Francisco, California, United States of America
- P. Weinstock, Cooper University Health Care, Camden, New Jersey, United States of America
- P. Wilson, Emory University, Atlanta, Georgia, United States of America
- M. Zema, Stony Brook University, Department of Medicine, New York, New York, United States of America
- P. Ziajka, Florida Lipid Institute, Winter Park, Florida, United States of America
- Z. Zineh, University of Florida College of Pharmacy, Gainesville, Florida, United States of America
Managing Editor
- Diane Drexleremail: [email protected]
